Over multiple vials, this adds up
Angiogenic AcSDKP generation Prolyl oligopeptidase cleaves TB4 and releases the tetrapeptide Ac-Ser-Asp-Lys-Pro, an autonomous angiogenic factor layered on top of TB4's direct effect on endothelial migration
And it promotes blood vessel growth through pathways that don't fully overlap with BPC-157's, which is part of why the two peptides seem to work better together than apart [3]
Our peptide therapies are carefully selected for their safety, efficacy, and alignment with our clean, wellness-driven philosophy
How does BPC-157 work, mechanism with real numbers
Peptides, Compounding Pharmacies, and the FDA: What Patients Actually Need to Know in 2026 There is a tremendous amount of confusion right now around peptides like BPC-157, TB-500, and GHK-Cu